Asia Pacific Sleep Apnea Diagnostics Market
Market Introduction
The Asia Pacific Sleep apnea diagnostics market includes the consolidated markets for China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Obstructive sleep apnea (OSA) is a sleep disease that affects a large number of Chinese people. Polysomnography is the gold standard for diagnosing OSA (PSG). Smart phone applications (apps) are now frequently used as a valuable source of health information. The quality of the information offered by these apps, on the other hand, has not been thoroughly evaluated. When compared to Caucasians, individuals of Chinese heritage appear to have OSA that is driven far more by their anatomical propensity and to a lesser extent by non-anatomical causes. PSG is offered in top-tier hospitals but not in primary care facilities in 2018, and when it is, it is frequently limited to a single department, limiting access for patients in other departments. According to population-based studies, at least 50 million Chinese people suffer from obstructive sleep apnea (OSA). The number of patients who received proper therapy and the types of therapies, on the other hand, are unknown.
A link between OSA and COVID-19 severity has been proposed based on parallels in pathophysiology and mutually promoting pathways that promote both infection risk and immune response to the virus. 8 OSA causes a cascade of persistent low-grade systemic inflammatory processes including oxidative stress as a result of increased creation and propagation of reactive oxygen species. The researchers looked at 4,668 patients with COVID-19, 443 of whom also had obstructive sleep apnea (OSA). Obstructive sleep apnea (OSA) was associated with a greater risk of overall mortality, both before any adjustment and after adjusting for demographics. Covid-19 has shown, as a chest specialist that it is one of the independent predictors of development of severe Covid pneumonia. Because any severe sleep apnea patient will have a very bad upper airway tone. There are many patients getting pneumonia in Covid-19, landing up in the ICU, just because they had sleep apnea and which was not treated. Covid-19 also has shown us that patient they have come with problem like snoring because many people started having psychological dyspnea, dyspnea means uncomfortable awareness of one's own breathing. There are more patients asking for getting themselves tested for sleep study. That's the new change which can be seen as clinicians. Changes imposed due to the pandemic have led to a surge in individuals reporting sleep problems. The findings raise the need to screen for worsening sleep patterns and use of sleeping aids, especially in more susceptible populations, namely, women and people with insecure livelihoods subjected to social isolation. With telehealth on the rise, those surveyed in Asia Pacific are open to online means to address sleep-related concerns, yet fear hinders many from getting tested for obstructive sleep apnea. The patient population and disease burden of sleep-disordered breathing (SDB), insomnia, and other sleeping disorders are quite high in China.
Strategic insights for the Asia Pacific Sleep Apnea Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Asia Pacific Sleep Apnea Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Asia Pacific Sleep Apnea Diagnostics Strategic Insights
Get more information on this report Asia Pacific Sleep Apnea Diagnostics Report Scope
Report Attribute
Details
Market size in 2021
US$ 106.92 Million
Market Size by 2028
US$ 162.98 Million
Global CAGR (2021 - 2028)
6.2%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Product
By End User
Regions and Countries Covered
Asia-Pacific
Market leaders and key company profiles
Get more information on this report Asia Pacific Sleep Apnea Diagnostics Regional Insights
Get more information on this report
Market Overview and Dynamics
The sleep apnea diagnostics market in Asia Pacific is expected to grow US$ 106.92 million in 2021 to US$ 162.98 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Significant rise in the geriatric population has increased the prevalence of OSA. The occurrence of sleep apnea is more in the geriatric population due to presence of other related diseases. The higher occurrence of the OSA is attributed to the decline in the size of upper airway lumen due to increasing age factor. This factor is driving the sleep apnea diagnostics market substantially. Another key factor is the upsurge in the growing population. Several countries such as Japan, and developing countries such as China, India, and South Korea are experiencing significant growth in their geriatric population base. The growth of the geriatric population in these countries is driven by improved healthcare facilities and better healthcare services, leading increased life expectancy. Thus, the rise in geriatric population is among the key driving factors for the growth of the sleep apnea diagnostics market.
Key Market Segments
In terms of product, the polysomnography (PSG) device segment accounted for the largest share of the Asia Pacific sleep apnea diagnostics market in 2021. In term of end user, hospitals and sleep laboratories segment held a larger market share of the sleep apnea diagnostics market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the sleep apnea diagnostics market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are ResMed, Inc.; Nihon Kohden Corporation LLC; SOMNOmedics GmbH; Cleveland Medical Devices Inc.; Koninklijke Philips N.V.; Natus Medical Incorporated; Itamar Medical Ltd.; Compumedics Limited; and Drive DeVilbiss International among others.
Reasons to buy report
Asia Pacific Sleep Apnea Diagnostics Market Segmentation
Asia Pacific Sleep Apnea Diagnostics Market – By Product
Asia Pacific Sleep Apnea Diagnostics Market – By
End User
Asia Pacific Sleep Apnea Diagnostics Market – By
Country
Asia Pacific Sleep Apnea Diagnostics Market – Companies Mentioned
The Asia Pacific Sleep Apnea Diagnostics Market is valued at US$ 106.92 Million in 2021, it is projected to reach US$ 162.98 Million by 2028.
As per our report Asia Pacific Sleep Apnea Diagnostics Market, the market size is valued at US$ 106.92 Million in 2021, projecting it to reach US$ 162.98 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.
The Asia Pacific Sleep Apnea Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Sleep Apnea Diagnostics Market report:
The Asia Pacific Sleep Apnea Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Sleep Apnea Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Sleep Apnea Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Sleep Apnea Diagnostics Market
